HCM
MRK icon

Harvey Capital Management’s Merck MRK Stock Holding History

Harvey Capital Management’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$321K Sell
2,497
-3
-0.1% -$351 0.07% 75
2026
Q1 		$301K Hold
2,500
– – 0.07% 71
2025
Q4 		$263K Hold
2,500
– – 0.06% 71
2025
Q3 		$210K Hold
2,500
– – 0.04% 83
2025
Q2 		$205K Sell
2,500
-300
-11% -$23.8K 0.05% 77
2025
Q1 		$251K Hold
2,800
– – 0.07% 75
2024
Q4 		$279K Hold
2,800
– – 0.07% 76
2024
Q3 		$318K Hold
2,800
– – 0.08% 66
2024
Q2 		$347K Hold
2,800
– – 0.09% 70
2024
Q1 		$369K Hold
2,800
– – 0.11% 65
2023
Q4 		$305K Hold
2,800
– – 0.1% 64
2023
Q3 		$288K Hold
2,800
– – 0.1% 65
2023
Q2 		$323K Hold
2,800
– – 0.12% 69
2023
Q1 		$298K Hold
2,800
– – 0.12% 71
2022
Q4 		$311K Hold
2,800
– – 0.13% 69
2022
Q3 		$241K Hold
2,800
– – 0.1% 70
2022
Q2 		$255K Hold
2,800
– – 0.1% 71
2022
Q1 		$229K Sell
2,800
-38,585
-93% -$3.04M 0.07% 73
2021
Q4 		$3.17M Buy
41,385
+50
+0.1% +$3.98K 0.98% 37
2021
Q3 		$3.1M Sell
41,335
-1,100
-3% -$83.7K 1.06% 33
2021
Q2 		$3.3M Sell
42,435
-3,425
-7% -$255K 1.09% 33
2021
Q1 		$3.37M Buy
45,860
+943
+2% +$69.6K 1.22% 32
2020
Q4 		$3.5M Buy
44,917
+105
+0.2% +$8.03K 1.42% 26
2020
Q3 		$3.55M Sell
44,812
-441
-1% -$34.5K 1.58% 21
2020
Q2 		$3.34M Buy
+45,253
New +$3.41M 1.65% 20
2020
Q1 		– Sell
-2,620
Closed -$227K – 77
2019
Q4 		$227K Hold
2,620
– – 0.1% 73
2019
Q3 		$210K Hold
2,620
– – 0.1% 73
2019
Q2 		$209K Hold
2,620
– – 0.1% 76
2019
Q1 		$207K Buy
+2,620
New +$196K 0.1% 75

Other funds holding MRK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Harvey Capital Management's MRK Position: Q2 2026 in Review

Harvey Capital Management reduced its Merck (MRK) stake by 0.12% in Q2 2026, selling an estimated $351 and leaving 2,497 shares worth $321K. The position accounts for 0.07% of the portfolio, ranked #75.

Harvey Capital Management first reported a position in MRK in Q1 2019 and has held it in 29 quarters since. The position peaked at $3.55M in Q3 2020. 3,833 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Harvey Capital Management held 2,497 shares of Merck worth $321K as of Q2 2026.
  • Harvey Capital Management sold 3 Merck shares in Q2 2026, an estimated $351.
  • Merck made up 0.07% of Harvey Capital Management's portfolio in Q2 2026, its #75 holding.
  • Harvey Capital Management first reported a position in Merck in Q1 2019 and has held it in 29 quarters since.
  • Harvey Capital Management's Merck position peaked at $3.55M in Q3 2020.
  • 3,833 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Harvey Capital Management's 13F filing for Q2 2026, filed 17 Aug 2026.